Value of next generation sequencing (NGS) testing in advanced cancer patients.
Jesse D OrtendahlGebra Cuyun CarterSnehal G ThakkarKatalin BognarDavid W HallYara G AbdouPublished in: Journal of medical economics (2024)
Compared to single-gene testing, results indicate that using next generation sequencing test such as OncoExTra identified more actionable alterations, leading to improved outcomes and reduced costs.